Scarica l'app Stockscreener
1.15
0.88%
0.01
Calidi Biotherapeutics Inc Borsa (CLDI) Ultime notizie
Calidi Biotherapeutics Gains FDA Nod for Brain Cancer Trial - TipRanks
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 - U.S. Politics Today
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma - The Manila Times
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application - The Bakersfield Californian
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma - StockTitan
Calidi Biotherapeutics announces board changes and auditor ratification - Investing.com
Calidi Biotherapeutics Presents Antitumor Virotherapy Advances - TipRanks
Calidi Biotherapeutics stock target cut by Baird with Outperform tag maintained - Investing.com
Calidi price target lowered to $2.50 from $20 at Baird - TipRanks
CLDI Stock Earnings: Calidi Biotherapeutics Beats EPS for Q2 2024 - MSN
Calidi Biotherapeutics Inc (CLDI) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
CLDI Stock Plummets to 52-Week Low at $1.41 Amid Market Turbulence - Investing.com
Calidi Biotherapeutics Unveils Redtail Biopharma Subsidiary - TipRanks
Calidi Biotherapeutics announces board reduction following director's exit By Investing.com - Investing.com South Africa
Calidi Biotherapeutics announces board reduction following director's exit - Investing.com
Calidi Biotherapeutics announces board reduction following director's exit By Investing.com - Investing.com Australia
Calidi Biotherapeutics Board Reshuffles as Advisor Departs - TipRanks
Calidi Biotherapeutics (NYSE:CLDI) Releases Earnings Results - Defense World
Calidi Biotherapeutics (NYSE:CLDI) Issues Quarterly Earnings Results - MarketBeat
CLDI Stock Earnings: Calidi Biotherapeutics Beats EPS for Q2 2024 - InvestorPlace
Why Calidi Biotherapeutics is Moving Higher Monday - MSN
Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results - BioSpace
Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results - The Bakersfield Californian
Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results - GlobeNewswire
Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results - StockTitan
Biotech Spins Off Subsidiary for Stem Cell Therapy - San Diego Business Journal
UMACUnusual Machines, Inc. Latest Stock News & Market Updates - StockTitan
GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - StockTitan
Metric Analysis: Calidi Biotherapeutics Inc (CLDI)’s Key Ratios in the Limelight - The Dwinnex
CLDI’s price-to-cash ratio: How it affects the stock’s valuation. - US Post News
Calidi Biotherapeutics Secures Investment, Expands Advisory Board - TipRanks
Calidi Biotherapeutics Announces Launch of Nova Cell - GlobeNewswire
Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor - Yahoo Finance
A significant driver of top-line growth: Calidi Biotherapeutics Inc (CLDI) - SETE News
CLDI underperforms with a -9.66 decrease in share price - US Post News
An In-Depth Look at Calidi Biotherapeutics Inc Inc. (CLDI) Price Performance During Market Crashes - The InvestChronicle
Calidi announces issuance of U.S. patent on SuperNova tech platform - TipRanks
Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform - GlobeNewswire
Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform - StockTitan
Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform - Yahoo Finance
The Calidi Biotherapeutics Inc (CLDI) had a good session last reading, didn’t it? - US Post News
CLDICalidi Biotherapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board - GlobeNewswire
Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board - Yahoo Finance
Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board - StockTitan
Calidi Biotherapeutics announces 1-for-10 reverse stock split - Investing.com
Scotiabank maintains $245 target on Diamondback Energy By Investing.com - Investing.com Canada
Calidi Biotherapeutics announces 1-for-10 reverse stock split By Investing.com - Investing.com Canada
Calidi Biotherapeutics announces 1-for-10 reverse stock split By Investing.com - Investing.com India
Market Recap: Calidi Biotherapeutics Inc (CLDI)’s Positive Momentum, Closing at 0.16 - The Dwinnex
Calidi Biotherapeutics (NYSE:CLDI) Shares to Reverse Split on Monday, July 15th - Defense World
Are Smart Investors Making the Right Decision? Calidi Biotherapeutics Inc (CLDI) - SETE News
Calidi Biotherapeutics Inc (AMEX: CLDI) Is The Number One Stock Currently Moving. - Stocks Register
Why Calidi Biotherapeutics (CLDI) Shares Are Trading Lower - MSN
Calidi Biotherapeutics Inc (CLDI) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
Upward Trajectory: Calidi Biotherapeutics Inc (CLDI) Posts a Slidee, Closing at 0.16 - The Dwinnex
Kintara Therapeutics restructures share designations By Investing.com - Investing.com
Calidi Biotherapeutics secures $600K loan agreement By Investing.com - Investing.com UK
Why Calidi Biotherapeutics (CLDI) Shares Are Trading Lower - Benzinga
What was Calidi Biotherapeutics Inc (CLDI)’s performance in the last session? - US Post News
Calidi to effect 1-for-10 reverse stock split - TipRanks
Calidi Biotherapeutics announces 1-for-10 reverse stock split By Investing.com - Investing.com
0.01%
1.83%
Capitalizzazione:
|
Volume (24 ore):